Oncolytics Biotech® Reports 2021 Third Quarter Development Highlights and Financial Results

Go back to Oncolytics Biotech® Reports 2021 Third Quarter Development Highlights and Financial Results

Oncolytics Biotech (ONCY) Tops Q3 EPS by 3c

November 5, 2021 7:13 AM EDT

Oncolytics Biotech (NASDAQ: ONCY) reported Q3 EPS of ($0.09), $0.03 better than the analyst estimate of ($0.12).

For earnings history and earnings-related data on Oncolytics Biotech (ONCY) click here.

... More